Earnings Feed
Start Free
$IRD·4

REXAHN PHARMACEUTICALS, INC. · Jan 24, 5:50 PM ET

REXAHN PHARMACEUTICALS, INC. 4

4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 24, 2017

Insider Transaction Report

Form 4
Period: 2017-01-20
REXAHN PHARMACEUTICALS, INC.RNN
Suzdak Peter David
Chief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2017-01-20+1,175,000→ 1,175,000 total
    Exercise: $0.18Exp: 2027-01-20→ Common Stock (1,175,000 underlying)
  • Award

    Restricted Stock Units

    2017-01-20+250,000→ 250,000 total
    → Common Stock (250,000 underlying)
Footnotes (3)
  • [F1]One quarter of the option vests and becomes exercisable on January 20, 2018, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4